Aorta

JANS Article

A Promising Heart Drug Fails, Challenging a Long-Held Theory of Disease

September 10, 2026 | Vincent SierGold Contributor

Novo Nordisk reported that the ZEUS study, which involved more than 6,300 patients with heart disease or advanced kidney disease, failed to show a benefit for ziltivekimab vs placebo. Ziltivekimab lowered interleukin-6 and C-reactive protein,...

Podcast

The Beat With Joel Dunning Ep. 174: Surgical Treatment of Atrial Fibrillation

September 17, 2026 | Joel DunningGold ContributorSilver Commentor…

This week on The Beat, CTSNet Editor-in-Chief Joel Dunning spoke with James Cox, Professor of Cardiac Surgery at the Feinberg School of Medicine at Northwestern Medicine in Chicago, Illinois, USA,...

JANS Article

The Ross Procedure: Determinants of Long-Term Durability

September 17, 2026 | Shrikar Modukuri

This propensity-matched study from the Montreal Heart Institute Ross Registry examined sex-based differences in outcomes following the Ross procedure. Among 816 adults undergoing full-root pulmonary autograft replacement (2011 to 2025),...

JANS Article

Supra-Annular Perceval Bentall: From Concept to Patient

September 17, 2026 | Vincent SierGold Contributor

This technical report describes the SUpra-annular PERceval Bentall (SUPERB), which utilized a Perceval Plus XL sutureless bovine pericardial valve inside a 28 mm Valsalva Dacron graft. Ex vivo testing involved...

Podcast

The Beat With Joel Dunning Ep. 173: Uniportal Robotics in the UAE

September 10, 2026 | Joel DunningGold ContributorSilver Commentor

This week on The Beat, CTSNet Editor-in-Chief Joel Dunning spoke with Taj Mohammed Fiyaz Chowdhry, a consultant thoracic surgeon at Burjeel Specialty Hospital, Sharjah, UAE, about uniportal robotics in the...

JANS Article

Complete Dacron Reinforcement of Ross Autograft Does Not Increase Neo-Aortic Valve Regurgitation: A Systematic Review and Meta-Analysis

July 2, 2026 | Ahmed Wahba

Autograft dilation and neo-aortic regurgitation remain key concerns after the Ross procedure. This meta-analysis of 526 patients shows complete Dacron reinforcement yields comparable outcomes to unsupported or partially supported techniques...

Video

Resection of a Cardiac Sarcoma

July 1, 2026 | Tiziano Torre…

This case involved a 74-year-old woman who complained of dyspnea on exertion for the past three weeks. She also reported dysphagia for solids without experiencing weight loss. The patient had...

Video

Ross Procedure With Internal and External Reduction Annuloplasty Using Autologous Tissue Rings

June 30, 2026 | Emily Scheffel…

This video presents a Ross procedure with internal and external reduction annuloplasty using autologous tissue rings. The patient was a 41-year-old previously healthy male who presented after a syncopal episode....

Video

Hemi-Commando Procedure for Bioprosthetic Aortic Valve Endocarditis

June 29, 2026 | Scarlett Tohme…

A 74-year-old male with hypertension, hyperlipidemia, paroxysmal atrial fibrillation, and a previous transcatheter bioprosthetic aortic valve of less than one year presented to an outside facility with repetitive embolic phenomenon...

Event

2nd Annual Cleveland Aortic Symposium: Aortic Dissection – Type A, Type B, Non-A-Non-B

August 28, 2026

Friday, August 28, 2026 – Saturday, August 29, 2026 @ 7:00 am – 12:30 pm – Join a panel of leading national and international experts for an immersive learning experience....

Podcast

The Beat With Joel Dunning Ep. 162: Lifetime Management of Aortic Valve Disease

June 25, 2026 | Joel DunningGold ContributorSilver Commentor…

This week on The Beat, CTSNet Editor-in-Chief Joel Dunning spoke with Dr. Isaac George, CTSNet Board Member and Co-Director of the Structural Heart and Valve Center, Surgical Director of Structural...

JANS Article

In Vivo Base Editing of PCSK9 With VERVE-102 for Hypercholesterolemia

June 25, 2026 | Vincent SierGold Contributor

In this article, the authors report interim results of Heart 2, a phase 1, open label, single ascending dose study of VERVE 102, a GalNAc lipid nanoparticle delivering mRNA for...

JANS Article

Valve-Sparing Aortic Root Replacement: Defining High-Volume Centres Using Prospective Data

June 25, 2026 | Mujtaba MubashirGold Contributor

This multicenter registry study evaluated the volume-outcome relationship in elective valve-sparing aortic root replacement (VSARR) to establish a threshold for high-volume centers. Utilizing prospective data from 2,668 patients across 37...

LOAD MORE
ADVERTISE ON CTSNET